ExpreS2ion Biotech Holding AB rights issue of SEK 131m.

Arctic Securities acted as financial advisor to the Danish Nasdaq First North listed company ExpreS2ion Biotech Holding AB (publ) in relation to the rights issue of SEK 131m. The rights issue was received with great interest which resulted in a subscription of over 140 percent (SEK 186m). We are grateful for the vote of confidence and congratulate on the successful transaction!

Latest news

  1. Arctic Securities -

    Cavendish Hydrogen ASA - Prospectus

    Cavendish Hydrogen has applied for admission to trading of its shares on the main board of the Oslo Stock Exchange. Arctic Securities AS is acting as joint lead manager. Please find the prospectus in connection with the Listing.